Astellas
Astellas

Groundbreaking $800m Cancer Partnership Revolutionizes Treatment
BIOT
🔍 Sorry, the requested page cannot be found. Please go back to the home page. 🏠 AstellasXyphos Kelonia CancerResearch Partnership

Revolutionary Gut-on-Chip Tech: Transforming Biologic Drug Testing
BIOT
🔍 Vivtex and Astellas team up to create oral biologic Gut-on-Chip tech, revolutionizing drug testing and therapy development. 💊🧪

Astellas’ Gastric Cancer Treatment Rejected by FDA Blames CDMO
BIOT
📢 Astellas' gastric cancer antibody rejected by FDA due to CDMO issues. Setback for treatment, importance of reliable CDMO highlighted. 😞🔍🏭📉💡





